Wouter A. van der Zwan

Long-Term Efficacy, Survival, and Safety of [177Lu-DOTA0,Tyr3]octreotate in Patients with Gastroenteropancreatic and Bronchial Neuroendocrine Tumors

Tessa Brabander, Wouter A. van der Zwan, Jaap J.M. Teunissen et al. · Clinical Cancer Research · 2017 · 604 citations

Medicine, Oncology, Pharmacology +17

Probing Intracellular Motor Protein Activity Using an Inducible Cargo Trafficking Assay

Lukas C. Kapitein, Max A. Schlager, Wouter A. van der Zwan et al. · Biophysical Journal · 2010 · 187 citations · Full text

Life Sciences, Cell Biology, Molecular Biology +14

Nephrotoxicity after PRRT with 177Lu-DOTA-octreotate

Hendrik Bergsma, Mark Konijnenberg, Wouter A. van der Zwan et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2016 · 174 citations · Full text

Medicine, Nephrology, Nuclear Medicine +9

Salvage peptide receptor radionuclide therapy with [177Lu-DOTA,Tyr3]octreotate in patients with bronchial and gastroenteropancreatic neuroendocrine tumours

Wouter A. van der Zwan, Tessa Brabander, Boen L.R. Kam et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2018 · 137 citations · Full text

Medicine, Nuclear Medicine, Oncology +15

PRRT genomic signature in blood for prediction of 177Lu-octreotate efficacy

Lisa Bodei, Mark Kidd, Aviral Singh et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2018 · 131 citations

Medicine, Hematology, Pharmacology +8